worth watching.., page-17

"Very difficult for me to justify watching something like that and at the same regard it as investment research."

Rob, people who wouldn't watch something that might disagree with their view of how similar drugs to C-Vac are perceived in the real world shouldn't be shoving their opinions down peoples' throats at every available opportunity.

I really have to wonder what you actually consider is appropriate 'investment research'. It seems to consist solely on reading Prima's announcements with a very uncritical eye and rehashing them endlessly on the Prima threads.

I'm not attempting to downramp and I am not saying that the current shareprice is overvalued. Compared to similar companies in the US, is is actually undervalued, but programs like this help to put the difficulties of getting a drug into actual patients, even when it is commercialised, into perspective.